Characterizing the effects of Mouse Maturation on the Expression of Acute Renal F

表征小鼠成熟对急性肾 F 表达的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): Mice have become the most commonly used animal species for studies of experimental acute kidney injury (AKI) and acute renal failure (ARF). This preference stems from a variety of factors, including relative cost, the heterogeneity of available strains, the availability of protean molecular probes for studying this species, and their utility for induction of specific genetic alterations, such as whole animal- or tissue specific- gene knock-outs. For a variety of reasons, most studies are performed when the mice are within the first 4 months of life. However, our laboratory has recently observed that during this early maturation period, which corresponds with rapid growth (e.g., a 3x increase in body weight), there is a profound change in renal susceptibility to diverse forms of attack. Thus, whereas 1 month old mice are almost completely resistant to at least three ARF models, 4 month old mice subjected to the same injury protocols sustain severe tubular necrosis, cast formation, and filtration failure. The goal of the proposed work is to better characterize, and to gain initial insights into, how this change from an "injury resistant" to an "injury sensitive" phenotype occurs. This work is deemed to be important for the following reasons: 1) it may have potentially profound implications for the conduct, and interpretation of, future studies of AKI; 2) new insights into critical determinants of cellular injury, in general, could result; and 3) understanding why 1 month old mice have profound resistance to tubular injury could potentially lead to new therapeutic insights. Towards these ends, four Specific Aims are proposed: Specific Aim 1 will further characterize determinants of this maturation - AKI susceptibility effect at the whole animal level (further definition of age, sex, and strain effects on AKI susceptibility and recovery rates). Whether this age dependent switch in injury susceptibility is renal specific, or whether it is also expressed in extra-renal tissues, will be determined. Specific Aim 2 will assess potential biochemical pathways through which this changing cell phenotype occurs (primary alterations in cellular energetics, oxidant stress, phospholipid hydrolysis, inflammation, apoptosis). If the maturation process has a dominant impact on a specific injury- inducing pathway, subsequent studies will be designed to address underlying molecular mechanisms. Specific Aims 3 and 4 will further characterize why two critical cytoprotective pathways, HMG CoA reductase (Aim 3), and heme oxygenase-1 (Aim 4), are in flux during the early maturation process, and whether these changes impact renal susceptibility to AKI / ARF. These experiments have been designed to generate (Aims 1 & 2), and preliminarily test (Aim 3 &4), new hypotheses for future study. Hence, a two year study (R-21) is proposed to gain initial insights that will help focus more in depth future investigation. PUBLIC HEALTH RELEVANCE: As animals, and presumably humans, grow and develop, their kidneys become progressively more sensitive to injury. The goal of this application is to determine why this occurs, because this will yield new insights into mechanisms of disease. The ultimate goal is to develop pharmacologic strategies that can protect high risk patients from the onset of severe, acute kidney injury and its adverse sequelae that frequently result in death.
描述(由申请人提供):小鼠已成为研究实验性急性肾损伤(AKI)和急性肾功能衰竭(ARF)最常用的动物物种。这种偏好源于多种因素,包括相对成本、现有菌株的异质性、用于研究该物种的蛋白质分子探针的可用性,以及它们对诱导特定遗传改变的有效性,例如整个动物或组织特异性基因敲除。由于各种原因,大多数研究都是在小鼠出生后4个月内进行的。然而,我们的实验室最近观察到,在与快速生长相对应的早期成熟期(例如,体重增加3倍),肾脏对各种形式攻击的易感性发生了深刻的变化。因此,1个月大的小鼠对至少三种ARF模型几乎完全耐受,而4个月大的小鼠在相同的损伤方案下出现严重的肾小管坏死、管型形成和滤过失败。这项拟议工作的目标是更好地刻画并初步了解这种从“伤害抵抗”到“伤害敏感”表型的变化是如何发生的。这项工作被认为很重要,原因如下:1)它可能对AKI的进行和解释产生潜在的深远影响;2)对细胞损伤的关键决定因素可能会产生新的见解;以及3)理解为什么1个月大的小鼠对肾小管损伤有深刻的抵抗力可能会导致新的治疗见解。为此,提出了四个具体目标:具体目标1将在整个动物水平上进一步描述这种成熟-AKI易感性效应的决定因素(进一步定义年龄、性别和应变对AKI易感性和恢复率的影响)。这种损伤易感性的年龄依赖性开关是肾脏特有的,还是在肾外组织中也有表达,将被确定。具体目标2将评估发生这种细胞表型变化的潜在生化途径(细胞能量学的主要变化、氧化应激、磷脂水解、炎症、细胞凋亡)。如果成熟过程对特定的损伤诱导途径具有主导影响,后续研究将被设计用于解决潜在的分子机制。特定的AIMS 3和4将进一步描述为什么两个关键的细胞保护通路,HMG CoA还原酶(AIM 3)和血红素加氧酶-1(AIM 4)在早期成熟过程中处于流动状态,以及这些变化是否影响肾脏对AKI/ARF的易感性。这些实验旨在为未来的研究产生新的假设(目标1和2),并初步检验(目标3和4)。因此,建议进行一项为期两年的研究(R-21),以获得初步的见解,这将有助于将重点放在未来更深入的调查上。与公共卫生相关:随着动物,大概还有人类的成长和发育,它们的肾脏对伤害越来越敏感。这项应用的目标是确定为什么会发生这种情况,因为这将对疾病的机制产生新的见解。最终目标是开发能够保护高危患者免受严重、急性肾损伤及其经常导致死亡的不良后遗症影响的药物策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard A. Zager其他文献

A Search for Nephrotoxic Factors Within the Uremic Milieu
  • DOI:
    10.1016/s0272-6386(82)80058-9
  • 发表时间:
    1982-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Richard A. Zager;Gail Johannes
  • 通讯作者:
    Gail Johannes
48th Scientific Meeting of the Dutch Society of Nephrology
  • DOI:
    10.1038/ki.1994.418
  • 发表时间:
    1994-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Richard A. Zager
  • 通讯作者:
    Richard A. Zager
49th Scientific Meeting of the Dutch Society of Nephrology
  • DOI:
    10.1038/ki.1994.419
  • 发表时间:
    1994-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Richard A. Zager
  • 通讯作者:
    Richard A. Zager
Susceptibility of the Proximal Tubular Brush Border to Acute Obstructive Injury
  • DOI:
    10.1016/s0022-5347(17)53787-8
  • 发表时间:
    1982-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Richard A. Zager;Gail A. With the Technical Assistance of; Johannes
  • 通讯作者:
    Johannes
Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
RBT-1 对接受冠状动脉搭桥术或心脏瓣膜手术的患者预处理反应生物标志物的影响:一项多中心、双盲、随机、安慰剂对照 2 期试验
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
    A. Lamy;Glenn M. Chertow;M. Jessen;Alonso Collar;Craig D. Brown;Charles A. Mack;M. Marzouk;Vincent Scavo;T. B. Washburn;David Savage;Julian Smith;J. Bennetts;Roland Assi;Christian Shults;Arman Arghami;J. Butler;P. Devereaux;Richard A. Zager;Chao Wang;Steve Snapinn;A. Browne;Jeannette Rodriguez;S. Ruiz;Bhupinder Singh;Glenn M. Chertow;Craig D. Brown;Charles A. Mack;Julian Smith;Dominic Tedesco;John MacArthur;Jonathan Praetor;Divyakant Gandhi;Joel Corvera
  • 通讯作者:
    Joel Corvera

Richard A. Zager的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard A. Zager', 18)}}的其他基金

Characterizing the effects of Mouse Maturation on the Expression of Acute Renal F
表征小鼠成熟对急性肾 F 表达的影响
  • 批准号:
    7842690
  • 财政年份:
    2009
  • 资助金额:
    $ 26.4万
  • 项目类别:
Iron Therapy in Renal Disease: Potential Toxicities
肾脏疾病的铁疗法:潜在毒性
  • 批准号:
    7077742
  • 财政年份:
    2004
  • 资助金额:
    $ 26.4万
  • 项目类别:
Iron Therapy in Renal Disease: Potential Toxicities
肾脏疾病的铁疗法:潜在毒性
  • 批准号:
    7223514
  • 财政年份:
    2004
  • 资助金额:
    $ 26.4万
  • 项目类别:
Iron Therapy in Renal Disease: Potential Toxicities
肾脏疾病的铁疗法:潜在毒性
  • 批准号:
    7426428
  • 财政年份:
    2004
  • 资助金额:
    $ 26.4万
  • 项目类别:
Iron Therapy in Renal Disease: Potential Toxicities
肾脏疾病的铁疗法:潜在毒性
  • 批准号:
    6917161
  • 财政年份:
    2004
  • 资助金额:
    $ 26.4万
  • 项目类别:
Iron Therapy in Renal Disease: Potential Toxicities
肾脏疾病的铁疗法:潜在毒性
  • 批准号:
    6802635
  • 财政年份:
    2004
  • 资助金额:
    $ 26.4万
  • 项目类别:
ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
急性肾功能衰竭——氟化麻醉剂的影响
  • 批准号:
    2665685
  • 财政年份:
    1998
  • 资助金额:
    $ 26.4万
  • 项目类别:
ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
急性肾功能衰竭——氟化麻醉剂的影响
  • 批准号:
    6177867
  • 财政年份:
    1998
  • 资助金额:
    $ 26.4万
  • 项目类别:
ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
急性肾功能衰竭——氟化麻醉剂的影响
  • 批准号:
    2906254
  • 财政年份:
    1998
  • 资助金额:
    $ 26.4万
  • 项目类别:
ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
急性肾功能衰竭——氟化麻醉剂的影响
  • 批准号:
    6381176
  • 财政年份:
    1998
  • 资助金额:
    $ 26.4万
  • 项目类别:

相似海外基金

Acute Kidney Failure in a Cancer ICU
癌症 ICU 中的急性肾衰竭
  • 批准号:
    7034020
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
Acute Kidney Failure in a Cancer ICU
癌症 ICU 中的急性肾衰竭
  • 批准号:
    7459945
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
Acute Kidney Failure in a Cancer ICU
癌症 ICU 中的急性肾衰竭
  • 批准号:
    7922716
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
Acute kidney failure: investigation and treatment of ki dney cell injury
急性肾衰竭:肾细胞损伤的调查和治疗
  • 批准号:
    nhmrc : 901011
  • 财政年份:
    1990
  • 资助金额:
    $ 26.4万
  • 项目类别:
    NHMRC Project Grants
Acute kidney failure: new methods of investigation and treatment
急性肾衰竭:研究和治疗的新方法
  • 批准号:
    nhmrc : 891081
  • 财政年份:
    1989
  • 资助金额:
    $ 26.4万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了